It’s possible NWBO allowed expiration of Cognate’s contract, I suppose, in order to shift to a BP’s CDMO, we simply haven’t been updated. I don’t think so though. Who currently has the DCVax-l manufacturing contract in the U.S.? You’d think it would be incumbent on NWBO to update this.